Effect of peptide carrier coupling on peptide specific immune responses

Immunobiology

Volumn 203, Issue 4, 2001, Pages 601-615

  Kirkley, Janet E ^a   Goldstein, Allan L ^b   Naylor, Paul H ^c  

^a KNOX COLLEGE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; ESTER DERIVATIVE; GAG PROTEIN; GLUTARALDEHYDE; KEYHOLE LIMPET HEMOCYANIN; MALEIMIDE; PEPTIDE ANTIBODY; SYNTHETIC PEPTIDE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CHEMICAL STRUCTURE; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0034999596     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(01)80010-3     Document Type: Article

References (34)

1. HAN, K.-K., C. RICHARD, and A. DELACOURTE. 1984. Chemical cross-links of proteins by using bifunctional reagents. Int. J. Biochem. 16: 129.
2. PEETERS, J. M., T. G. HAZENDONK, E. C. BEUVERY, and G. I. TESSER. 1989. Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicitry of the conjugates. J. Immunol. Methods 120: 133.
3. BRIAND, J. P., S. MULLER, and M. H. V. VAN REGENMORTEL. 1985. Synthetic peptides as antigens: Pitfalls ot conjugation methods. J. Immunol. Methods. 78: 59.
4. RONCO, J., M. CHEVALIER, M. KACZOREK, A. DESLANDRES, F. BARRE-SINOUSSIE, and M. GIRARD. 1991. Vaccines 91 : Modern Approaches to New Vaccines Including Prevention of AIDS, Cold Spring Harbor Press, N.Y., 441 pp.
5. SCHAAPER, W. M. M., H. LANKHOE, W. C. PUIJK, and R. H. MELEOEN. 1988. Manipulation of antipeptide immune response by varying the coupling of the peptide with the carrier protein. Molec. Immunol. 26: 81.
6. FRANCIS, M. J., G. Z. HASTINGS, B. E. CLARKE, A. L. BROWN, C. R. BEDDELL, D. J. ROWLANDS, and F. BROWN. 1990. Neutralising antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Immunol. 69: 171.
7. KIRKLEY, J. E., A. L. GOLDSTEIN, and P. H. NAYLOR. 1996. Adjuvant properties of Montanide CSA 720 with a recombinant HIV p17 gag protein and synthetic peptide antigens. Scand. J. Immunol. 43: 431.
8. NAYLOR, P. H., C. W. NAYLOR, M. BADAMCHIAN, S. WADA, A. L. GOLDSTEIN, S.-S. WANG, D. K. SUN, A. H. THORNTON, and P. S. SARIN. 1987. Human immunodeficiency virus contains an epitope immunoreactive with thymosin α1 and the 30-amino acid synthetic p17 group-specific antigen peptide HGP-30. Proc. Natl. Acad. Sci. USA 84: 2951.
9. BOUCHER, C. A. B., W. J. A. KRONE, J. GOUDSMIT, R. H. MELOEN, P. H. NAYLOR, A. L. GOLDSTEIN, D. K. SUN, and P. S. SARIN. 1990. Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30. J. Clin. Lab. Anal. 4: 43.
10. NAYLOR, P. H., M. B. SZTEIN, S. WADA, S. MAURER, D. HOLTERMAN, J. E. KIRKLEY, C. W. NAYLOR, B. C. ZOOK, R. A. HITZELBERG, C. J. GIBBS, D. ZAGURY, A. ACHOUR, C. O'TOOLE, B. GAZZARD, M. YOULE, A. RIOS, P. S. SARIN, and A. E. GOLDSTEIN. 1991. Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine - HGP-30-KLH. Int. J. Immunopharmac. 14(Suppl 1): 117.
11. KIRKLEY, J. E., P. H. NAYLOR, D. J. MARCIANI, C. R. KENSIL, M. NEWMAN, and A. L. GOLDSTEIN. 1992. Combination Therapies, Plenum Press, N.Y., 313 pp.
12. PAPSIDERO, L. D., M. SHEU, and F. W. RUSCETTI. 1989. Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: Characterization and epitope mapping. J. Virol. 63: 267.
13. FRANCIS, M. J. 1993. New Generation Vaccines, Plenum Press, N.Y., 225 pp.
14. TAINER, J. A., E. D. GETZOFF, H. ALEXANDER, R. A. HOUGHTEN, A. J. OLSON, R. A. LERNER, and W. A. HENDRICKSON. 1984. The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a protein. Nature 312: 127.
15. WESTHOE, E., D. ALTSCHUH, D. MORAS, A. C. BLOOMER, A. MONDRAGON, A. KLUG, and M. H. V. VAN REGENMORTEL. 1984. Correlation between segmental mobility and the location of antigenic determinants in proteins. Nature 311: 123.
16. COATES, A. R. M., J. COOKSON, G. J. BARTON, M. J. ZVELEBIL, and M. J. E. STERNBERG. 1987. AIDS vaccine predictions. Nature 326: 549.
17. DELISI, C., and J. A. BERZOFSKY. 1985. T-cell antigenic sites tend to be amphipathic structures. Proc. Natl. Acad. Sci. USA 82: 7048.
18. WAHREN, B., J. ROSEN, E. SANDSTROM, T. MATHIESEN, S. MODROW, and H. WIGZELL. 1989. HIV-1 peptides induce a proliferative response in lymphocytes from infested persons. J. AIDS 4: 448.
19. WILLER, A., A. ACHOUR, J. P. MBIKA, K. LAAROUBI, A. LACHGAR, A. NIHRANE, O. PICARD, P. H. NAYLOR, P. S. SARIN, A. I., GOLDSTEIN, and D. ZAGURY. 1992. Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virus. Biomed. & Pharmacother. 46: 359.
20. ACHOUR, A., O. PICARD, D. ZAGURY, P. S. SARIN, R. C. GALLO, P. H. NAYLOR, and A. L. GOLDSSTEIN. 1990. HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc. Natl. Acad. Sci. USA 87: 7045.
21. JIANG, J.-D., F.-N. CHU, P. H. NAYLOR, J. E. KIRKLEY, J. MANDELI, J. I. WALLACE, P. S. SARIN, A. L. GOLDSTEIN, J. F. HOLLAND, and J. G. BEKEST. 1992. Specific antihody responses to synthetic peptides of HIV-1 p17 correlate with different stages of HIV-1 infection. J. AIDS 5: 382.
22. ROTHBARD, J. B., and W. R. TAYLOR. 1988. A sequence pattern common to T cell epitopes. EMBO J. 7: 93.
23. ROTZSCHKE, O., and K. FALK. 1994. Origin, structure and motifs of naturally processed MHC class II ligands. Curr. Opin. Immunol. 6: 45.
24. RAMMENSEE, H.-G. 1995. Chemistry of peptides associated with MHC class I and class II molecules. Curr. Opin. Immunol. 7: 85.
25. SETTE, A., S. BUUS, E. APPELLA, J. A. SMITH, R. CHESNUT, C. MILES, S. M. COLON, and H. M. GREY. 1989. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. Proc. Natl. Acad. Sci. USA 86: 3296.
26. d. Science 256: 1817.
27. d-binding peptides derived from unrelated protein antigens share a common structural motif. J. Immunol. 141: 45.
28. SETTE, A., S. BUUS, S. COLON, C. MILES, and H. M. GREY. 1989. Structural analysis of peptides capable of binding to more than one Ia antigen. J. Immunol. 142: 35.
29. REAY, P. A., R. M. KANTOR, and M. M. DAVIS. 1994. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152: 3946.
30. TAKAHASHI, H., K. B. CEASE, and J. A. BERZOESKY. 1989. Identification of proteases that process distinct epitopes on the same protein. J. Immunol. 142: 2221.
31. KATUNUMA, N., Y. MATSUNAGA, A. MATSUI, H. KAKEGAWA, K. ENDO, T. INUBUSHI, T. SAIBARA, Y. OHBA, and T. KAKIUCHI. 1998. Novel physiological functions of cathepsins B and L on antigen processing and osteoclastic bone resorption. Adv. Enzyme Regul. 38: 235.
32. KATUNUMA, N., A. MATSUI, T. KAKEGAWA, E. MURATA, T. ASAO, and Y. OHBA. 1999. Study of the functional share of lysosomal cathepsins by the development of specific inhibitors. Adv. Enzyme Regul. 39: 247.
33. ZHANG, T., Y. MAEKAWA, H. HANBA, T. DAINICHI, B. F. NASHED, H. HISAEDA, T. SAKAI, T. ASAO, K. HIMENO, R. A. GOOD, and N. KATUNUMA. 2000. Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of the invariant chain in ovalbumin-immunized mice. Immunology 100: 13.
34. BARRETT, A. J. 1977. Proteinases in Mammalian Cells and Tissues, North-Holland Publishing Company, Amsterdam, 735 pp.